We use cookies for a better user experience. Read our Privacy Policy

I Agree

Bioinformatics Market

Bioinformatics Market (Platforms, Tools, and Services; and Application: Preventive Medicine, Molecular Medicine, Gene Therapy, Drug Development and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Bioinformatics Market Outlook 2031

  • The global market was valued at US$ 24.7 Bn in 2020
  • It is estimated to expand at a CAGR of 5.9% from 2021 to 2028
  • The global bioinformatics industry is expected to reach the value of US$ 44.9 Bn by the end of 2028

Analysts’ Viewpoint on Global Market Scenario

In order to accelerate pharma R&D across targets and disease areas amid the ongoing COVID-19 pandemic, stakeholders in the bioinformatics business are capitalizing on this trend to increase the availability of life-saving drugs. Bioinformatics is catering to the demand for advanced treatment of several diseases and effective preventive solutions. However, there is a need for integrated software platforms that cater to complex medical requirements of patients. Hence, market stakeholders should partner with tech providers to develop integrated software platforms. As such, a surge in R&D activities has led to a rise in data generation, which increases the demand for efficient technology for data management in the healthcare sector.

Bioinformatics Holds Potentials to Cut Down Costs for Drug Development

Bioinformatics is an important tool for managing the large data generated during the drug discovery process, starting from pre-clinical trials to target identification and screening. Bioinformatics data management stores data in one place, thereby enabling effective analysis of information whenever required. This helps in increasing the R&D productivity of a company by recognizing drug targets.

Bioinformatics technologies can save time and money, as it combines data into different interactive models to highlight disease pathway and aid drug discovery. Drug development can take years to complete and the cost associated could exceed millions of dollars. The use of bioinformatics has the potential to cut down these costs significantly. It can also help the companies overcome challenges of storing valuable and extensive processing data.

To know the scope of our report Get a Sample of the Bioinformatics Market

Need for Life-saving Therapeutics Boosts Demand for Bioinformatics Use during COVID-19 Pandemic

The ongoing COVID-19 pandemic has placed a high priority on identifying drugs to prevent or lessen clinical infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused by the coronavirus disease-2019 (COVID-19). Stakeholders in the market for bioinformatics are taking advantage of this opportunity to increase R&D in different computational approaches to identify potential therapeutics. They are investigating existing FDA-approved drugs that could block coronavirus from entering cells. Since coronavirus and its variants share a large genome, there is a need for bioinformatics to rapidly discover existing therapeutic agents that can be effective in reducing morbidity and mortality in patients.

Get a glimpse of the in-depth analysis through our Report Brochure

The proliferation of IT Translating into Revenue Opportunities for Software Developers

Diverse solutions of currently available bioinformatics platforms hamper the growth of the bioinformatics business. The need of combining the available software to build a composite application for current single-task tools is increasing. The tools should be compatible with each other to use the data. Current bioinformatics platforms do not offer a well-defined data format, which, in turn, restrains the growth of the global market for bioinformatics. Hence, stakeholders should team up with tech providers to innovate in bioinformatics platforms.

Bioinformatics is used to manage the data gathered from research & development projects in the biopharmaceutical, life sciences, and biotechnology industries. The growth of the bioinformatics market is driven by a rise in applications of IT in the healthcare sector, along with robust technological advancements. The usage of information technology or IT has enabled easy storage, processing, access, and retrieval of data.

Expanding operations in the future? To get the perfect launch to ask for a custom report

Bioinformatics Plays Instrumental Role in Preventive Medicine & Molecular Medicine

Significant investments by pharmaceutical companies in chemical and drug research are expected to drive the global market over the next few years. Bioinformatics platforms were initially considered IT tools; however, presently, these are used as integrated solutions that provide algorithms and statistical tools for data analysis. Bioinformatics solutions help in integrating data management and analysis for applications such as gene sequencing.

Bioinformatics has applications in preventive medicine, molecular medicine, gene therapy, drug development, and others. Other application areas include forensic analysis of microbes, genetic research for antibiotic resistance, and veterinary science. The molecular medicine segment accounted for the largest market share in 2020. The drug development segment is anticipated to expand at the highest CAGR from 2021 to 2028 in the bioinformatics market.

Strategic Collaborations Help Innovate in Bioinformatics Platforms

Key players in the global bioinformatics industry are expanding their market position by adopting various strategies such as mergers & acquisitions and research collaborations with other companies to launch innovative products and consolidate their market positions across the world.

A few expansion strategies adopted by players operating in the global bioinformatics market include the launch of the Pan-Cancer IVD (in vitro diagnostic) Test and innovations in cloud-based bioinformatics platforms.

Participants in the market are joining forces to introduce Next-Generation Sequencing (NGS)-based assay that analyzes cancer-relevant genetic alterations from DNA and RNA derived from a patient’s tumor in one integrated workflow.

Bioinformatics Industry: Overview

  • According to Transparency Market Research’s latest report on the global bioinformatics market for the historical period 2017–2019 and forecast period 2021–2028, rise in demand for nucleic acid & protein sequencing, increase in initiatives by private & government organizations, growth of proteomics & genomics, and surge in research on molecular biology & drug discovery

Increase in Usage of Bioinformatics in Drug Discovery: Key Driver

  • Bioinformatics is an important tool for managing the large data generated during the drug discovery process, starting from pre-clinical trials to target identification and screening. Bioinformatics data management stores the data in one place, thereby enabling effective analysis of information whenever required. This helps in increasing the R&D productivity of a company by recognizing drug targets.
  • Bioinformatics technologies can save time and money, as it combines data into different interactive models to highlight disease pathway and aid drug discovery. Drug development can take years to complete and the cost associated could exceed millions of dollars. The use of bioinformatics can cut down the cost by 33% to 38%. It can also help companies to overcome the challenges of storing valuable and extensive processing data.

Need of Integrated Solutions to Drive Market

  • Significant investments by pharmaceutical companies in chemical and drug research is expected to drive the global market in the next few years. Bioinformatics platforms were initially considered IT tools; however, presently, these are used as integrated solutions that provide algorithms and statistical tools for data analysis. Bioinformatics solutions help in integrating data management and analysis for applications such as gene sequencing.

Lack of Common Data Format: Key Restraint

  • Diverse solutions of currently available bioinformatics platforms hamper the growth of the bioinformatics industry. The need of combining the available software to build a composite application for current single-task tools is increasing. The tools should be compatible with each other to use the data. Current bioinformatics platforms do not offer a well-defined data format, which in turn restrains the bioinformatics market.

Bioinformatics Market: Competitive Landscape

  • This report profiles major players in the global bioinformatics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global market for bioinformatics is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global bioinformatics business are
    • Accelrys, Inc.
    • ID Business Solutions, Ltd.
    • Affymetrix, Inc.
    • CLC bio A/S
    • Agilent Technologies, Inc.
    • GenoLogics Life Sciences Software, Inc.
    • Life Technologies Corporation
    • Illumina, Inc.

Bioinformatics Market: Key Developments

  • Key players in the global bioinformatics indutry are expanding their market position by adopting various strategies such as mergers & acquisitions and research collaborations with other companies to launch innovative products and consolidate their market positions across the world. A few expansion strategies adopted by players operating in the global market for bioinformatics are:
    • In January 2021, Illumina launched the Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
    • In April 2020, HealthCare Global Enterprises and Strand Life Sciences introduced the StrandAdvantage500, a Next Generation Sequencing (NGS) based assay that analyzes cancer-relevant genetic alterations from DNA and RNA derived from a patient’s tumor in one integrated workflow.
  • The report on the global bioinformatics market discusses individual strategies, followed by company profiles of manufacturers of bioinformatics products. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global market.

Bioinformatics Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 24.7 Bn

Market Forecast Value in 2028

US$ 44.9 Bn

Growth Rate (CAGR)

5.9%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross-segment analysis at the global as well as regional levels. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market Player – Competition Matrix (by tier and size of companies)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Platform, Tools, and Services
    • Platform
      • Sequence Manipulation Platforms
      • Sequence Alignment Platforms
      • Structural Analysis Platforms
      • Sequence Analysis Platforms
    • Tools
      • General Knowledge Management Tools
      • Specialized Knowledge Management Tools
    • Services
      • Data Analysis
      • Sequencing Services
      • Database & Management
      • Other Services
  • By Application
    • Preventive Medicine
    • Molecular Medicine
    • Gene Therapy
    • Drug Development
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Accelrys, Inc.
  • ID Business Solutions, Ltd.
  • Affymetrix Inc.
  • CLC bio A/S
  • Agilent Technologies, Inc.
  • GenoLogics Life Sciences Software, Inc.
  • Life Technologies Corporation
  • Illumina, Inc.
  • Medtronic, Inc.
  • Omron Healthcare, Inc.
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Bioinformatics Market – Segmentation

Platforms, Tools, and Services
  • Platforms
    • Sequence Manipulation Platforms
    • Sequence Alignment Platforms
    • Structural Analysis Platforms
    • Sequence Analysis Platforms
  • Tools
    • General Knowledge Management Tools
    • Specialized Knowledge Management Tools
  • Services
    • Data Analysis
    • Sequencing Services
    • Database & Management
    • Other services
Application
  • Preventive Medicine
  • Molecular Medicine
  • Gene Therapy
  • Drug Development
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Bioinformatics Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of bioinformatics market?

The global market for bioinformatics is projected to reach a value of US$ 44.9 Bn by the end of 2028

What is the anticipated CAGR of the market for bioinformatics in the forecast period?

The global market is anticipated to grow at a CAGR of 5.9% during the forecast period

Which region is expected to project the highest market share in the global bioinformatics business?

North America accounted for a major share of the global bioinformatics market

What are the key driving factors for the growth of the global market for bioinformatics?

The market for bioinformatics is driven by a rise in applications of IT in the healthcare sector, along with robust technological advancements

Who are the key players in the global bioinformatics industry?

Key players in the global bioinformatics business include Accelrys, Inc., ID Business Solutions, Ltd., Affymetrix, Inc., CLC bio A/S, Agilent Technologies, Inc., GenoLogics Life Sciences Software, Inc., Life Technologies Corporation, and Illumina, Inc

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bioinformatics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Platforms, Tools, and Services Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Bioinformatics Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Software Analysis

    5.2. Technological Advancements

    5.3. Key Mergers, Acquisitions, Software launches

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Bioinformatics Market Analysis and Forecast, by Platforms, Tools, and Services

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031

        6.3.1. Platforms

            6.3.1.1. Sequence Manipulation Platforms

            6.3.1.2. Sequence Alignment Platforms

            6.3.1.3. Structural Analysis Platforms

            6.3.1.4. Sequence Analysis Platforms

        6.3.2. Tools

            6.3.2.1. General Knowledge Management Tools

            6.3.2.2. Specialized Knowledge Management Tools

        6.3.3. Services

            6.3.3.1. Data Analysis

            6.3.3.2. Sequencing Services

            6.3.3.3. Database & Management

            6.3.3.4. Other services

    6.4. Market Attractiveness Analysis, by Platforms, Tools, and Services

7. Global Bioinformatics Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Preventive Medicine

        7.3.2. Molecular Medicine

        7.3.3. Gene Therapy

        7.3.4. Drug Development

        7.3.5. Others

    7.4. Market Attractiveness Analysis, by Application

8. Global Bioinformatics Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Country/Region

9. North America Bioinformatics Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031

        9.2.1. Platforms

            9.2.1.1. Sequence Manipulation Platforms

            9.2.1.2. Sequence Alignment Platforms

            9.2.1.3. Structural Analysis Platforms

            9.2.1.4. Sequence Analysis Platforms

        9.2.2. Tools

            9.2.2.1. General Knowledge Management Tools

            9.2.2.2. Specialized Knowledge Management Tools

        9.2.3. Services

            9.2.3.1. Data Analysis

            9.2.3.2. Sequencing Services

            9.2.3.3. Database & Management

            9.2.3.4. Other services

    9.3. Market Value Forecast, by Application, 2017–2031

        9.3.1. Preventive Medicine

        9.3.2. Molecular Medicine

        9.3.3. Gene Therapy

        9.3.4. Drug Development

        9.3.5. Others

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Platforms, Tools, and Services

        9.5.2. By Application

        9.5.3. By Country

10. Europe Bioinformatics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031

        10.2.1. Platforms

            10.2.1.1. Sequence Manipulation Platforms

            10.2.1.2. Sequence Alignment Platforms

            10.2.1.3. Structural Analysis Platforms

            10.2.1.4. Sequence Analysis Platforms

        10.2.2. Tools

            10.2.2.1. General Knowledge Management Tools

            10.2.2.2. Specialized Knowledge Management Tools

        10.2.3. Services

            10.2.3.1. Data Analysis

            10.2.3.2. Sequencing Services

            10.2.3.3. Database & Management

            10.2.3.4. Other services

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Preventive Medicine

        10.3.2. Molecular Medicine

        10.3.3. Gene Therapy

        10.3.4. Drug Development

        10.3.5. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Platforms, Tools, and Services

        10.5.2. By Application

        10.5.3. By Country/Sub-region

11. Asia Pacific Bioinformatics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031

        11.2.1. Platforms

            11.2.1.1. Sequence Manipulation Platforms

            11.2.1.2. Sequence Alignment Platforms

            11.2.1.3. Structural Analysis Platforms

            11.2.1.4. Sequence Analysis Platforms

        11.2.2. Tools

            11.2.2.1. General Knowledge Management Tools

            11.2.2.2. Specialized Knowledge Management Tools

        11.2.3. Services

            11.2.3.1. Data Analysis

            11.2.3.2. Sequencing Services

            11.2.3.3. Database & Management

            11.2.3.4. Other services

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Preventive Medicine

        11.3.2. Molecular Medicine

        11.3.3. Gene Therapy

        11.3.4. Drug Development

        11.3.5. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Platforms, Tools, and Services

        11.5.2. By Application

        11.5.3. By Country/Sub-region

12. Latin America Bioinformatics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031

        12.2.1. Platforms

            12.2.1.1. Sequence Manipulation Platforms

            12.2.1.2. Sequence Alignment Platforms

            12.2.1.3. Structural Analysis Platforms

            12.2.1.4. Sequence Analysis Platforms

        12.2.2. Tools

            12.2.2.1. General Knowledge Management Tools

            12.2.2.2. Specialized Knowledge Management Tools

        12.2.3. Services

            12.2.3.1. Data Analysis

            12.2.3.2. Sequencing Services

            12.2.3.3. Database & Management

            12.2.3.4. Other services

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Preventive Medicine

        12.3.2. Molecular Medicine

        12.3.3. Gene Therapy

        12.3.4. Drug Development

        12.3.5. Others

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Platforms, Tools, and Services

        12.5.2. By Application

        12.5.3. By Country/Sub-region

13. Middle East & Africa Bioinformatics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031

        13.2.1. Platforms

            13.2.1.1. Sequence Manipulation Platforms

            13.2.1.2. Sequence Alignment Platforms

            13.2.1.3. Structural Analysis Platforms

            13.2.1.4. Sequence Analysis Platforms

        13.2.2. Tools

            13.2.2.1. General Knowledge Management Tools

            13.2.2.2. Specialized Knowledge Management Tools

        13.2.3. Services

            13.2.3.1. Data Analysis

            13.2.3.2. Sequencing Services

            13.2.3.3. Database & Management

            13.2.3.4. Other services

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Preventive Medicine

        13.3.2. Molecular Medicine

        13.3.3. Gene Therapy

        13.3.4. Drug Development

        13.3.5. Others

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Platforms, Tools, and Services

        13.5.2. By Application

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Market Share Analysis, by Company, 2020

    14.3. Company Profiles

        14.3.1. Accelrys, Inc.

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Product Portfolio

            14.3.1.3. SWOT Analysis

            14.3.1.4. Financial Overview

            14.3.1.5. Strategic Overview

        14.3.2. ID Business Solutions, Ltd.

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Product Portfolio

            14.3.2.3. SWOT Analysis

            14.3.2.4. Financial Overview

            14.3.2.5. Strategic Overview

        14.3.3. Affymetrix, Inc.

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Product Portfolio

            14.3.3.3. SWOT Analysis

            14.3.3.4. Financial Overview

            14.3.3.5. Strategic Overview

        14.3.4. CLC bio A/S

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Financial Overview

            14.3.4.5. Strategic Overview

        14.3.5. Agilent Technologies, Inc.

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Product Portfolio

            14.3.5.3. SWOT Analysis

            14.3.5.4. Financial Overview

            14.3.5.5. Strategic Overview

        14.3.6. Life Technologies Corporation

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Product Portfolio

            14.3.6.3. SWOT Analysis

            14.3.6.4. Financial Overview

            14.3.6.5. Strategic Overview

        14.3.7. Illumina, Inc.

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Product Portfolio

            14.3.7.3. SWOT Analysis

            14.3.7.4. Financial Overview

            14.3.7.5. Strategic Overview

        14.3.8. Other prominent players

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Product Portfolio

            14.3.8.3. SWOT Analysis

            14.3.8.4. Financial Overview

            14.3.8.5. Strategic Overview

List of Tables

Table 1: Market Snapshot: Global Bioinformatics Market (2020, 2028)

Table 2: Global Bioinformatics Market Revenue (US$ Mn), by Platforms, Tools and Services, 2018 - 2028

Table 3: Global Bioinformatics Market Revenue (US$ Mn), by Platforms, Tools  and Services, 2018 – 2028

Table 4: Global Platforms Market Revenue (US$ Mn), by Type, 2018–2028

Table 5: Global Content Management Tools Market Revenue (US$ Mn), 2018–2028

Table 6: Global Services Market Revenue (US$ Mn), by Types,  2018 – 2028

Table 7: Global Bioinformatics Market Revenue (US$ Mn), by Geography, 2018 – 2028

Table 8: North America Bioinformatics Market Revenue (US$ Mn), 2018 – 2028

Table 9: Europe Bioinformatics Market Revenue (US$ Mn), 2018 – 2028

Table 10: Asia Pacific Market Revenue (US$ Mn), 2018 – 2028

Table 11: Latin America Market Revenue (US$ Mn), 2018 – 2028

Table 12: Middle East & Africa Market Revenue (US$ Mn), 2018 – 2028

List of Figures

Figure 1: Bioinformatics Market Segmentation

Figure 2: Global Bioinformatics Market Revenue (US$ Mn), by Platforms, Content Management Tools and Services, 2013

Figure 3: Global Bioinformatics Market Revenue (US$ Mn), by Application, 2020

Figure 4: Comparative Analysis: Global Bioinformatics Market, by Geography, 2018 & 2020 (Value %)

Figure 5: Porter’s Five Force Analysis: Global Bioinformatics Market

Figure 6: Market Attractiveness Analysis: Global Bioinformatics Market, by Geography

Figure 7: Market Share by Key Players of the Global Bioinformatics Market, 2020 (%)

Figure 8: Value Chain Analysis: Global Bioinformatics Market

Figure 9: Global Sequence Manipulation Platforms Market Revenue (US$ Mn), 2018 - 2020

Figure 10: Global Sequence Alignment Platforms Market Revenue (US$ Mn), 2018- 2020

Figure 11: Global Structural Analysis Platforms Market Revenue (US$ Mn), 2018 - 2020

Figure 12: Global Sequence Analysis Platforms Market Revenue (US$ Mn), 2018 - 2020

Figure 13: Global General Knowledge Management Tools Market Revenue (US$ Mn), 2018 - 2020

Figure 14: Global Specialized Knowledge Management Tools Market Revenue (US$ Mn), 2018 - 2020

Figure 15: Global Data Analysis Services Market Revenue (US$ Mn), 2018– 2020

Figure 16: Global Sequencing Services Market Revenue (US$ Mn), 2018 - 2020

Figure 17: Global Database and Management Services Market Revenue (US$ Mn), 2018– 2020

Figure 18: Global Other Services Market Revenue (US$ Mn), 2018– 2020

Figure 19: Affymetrix, Inc.: Annual Revenue (US$ Mn), 2018 – 2028

Figure 20: Agilent Technologies Inc.: Annual Revenue (US$ Mn), 2018 – 2028

Figure 21: Life Technologies: Annual Revenue (US$ Mn), 2018 – 2028

Figure 22: Illumina, Inc.: Annual Revenue (US$ Mn), 2018 – 2028

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

959

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved